Lung cancer treatment in Istanbul, Turkey
Lung cancer comes in two main forms that are treated very differently — non-small cell lung cancer (about 85% of cases) and small cell lung cancer. Early non-small cell disease is often removed with surgery (a lobectomy, often minimally invasive), while radiation including stereotactic body radiation, chemotherapy, and biomarker-driven targeted therapy and immunotherapy carry the advanced and small-cell cases. Testing the tumour for EGFR, ALK, PD-L1 and other markers is essential to pick the right drugs. Istanbul hospitals offer this full pathway, often at JCI-accredited, state-authorized centers and well below Western-European prices for the same protocol. Every price we show is an illustrative placeholder until verified partner-hospital quotes exist — and you pay the hospital directly, never us. Start with a free 72-hour review of your reports before you decide anything.
Anatomy of the respiratory system: the trachea branching into bronchi and bronchioles, ending in the alveoli of the lungs.
SEER Training Modules, U.S. National Cancer Institute — public domain (opens in a new tab) ↗What lung cancer is
The U.S. National Cancer Institute describes lung cancer as cancer that forms in the tissues of the lung, usually in the cells lining the air passages. The NCI groups it into two main types that behave and are treated very differently: non-small cell lung cancer (NSCLC), which accounts for roughly 85% of cases, and small cell lung cancer (SCLC), which tends to grow and spread faster. The NCI lists cigarette smoking as the leading risk factor, along with second-hand smoke, radon, asbestos and other workplace exposures, and family history.
Diagnosis usually involves imaging such as a chest CT, a biopsy to confirm the type, and staging scans to see whether the disease has spread. For non-small cell tumours, the modern workup also includes molecular and biomarker testing of the tumour tissue, because the results decide which targeted or immunotherapy drugs can be used. Because early lung cancer often causes few symptoms, the NCI notes it can be found at a more advanced stage. Browse the wider cancer types hub for related diagnoses.
Treatment options
The modalities the NCI lists for lung cancer, and an honest note on each:
- Surgery. The backbone for early-stage non-small cell disease that can be removed — most often a lobectomy (removing the lobe containing the tumour), sometimes a smaller or larger resection, and increasingly done minimally invasively by video-assisted thoracoscopic surgery (VATS). See cancer surgery in Turkey.
- Radiation therapy. Used when surgery is not the right option — including stereotactic body radiation (SBRT), which delivers a high, precise dose to small inoperable tumours in a few sessions, as well as conventional radiation and chemoradiation. More on radiotherapy in Turkey.
- Chemotherapy. A backbone for small cell lung cancer and for advanced non-small cell disease, given on its own or combined with radiation or immunotherapy. Cost scales with the number of cycles. See chemotherapy in Turkey.
- Targeted therapy and immunotherapy. Central to modern non-small cell care: matched targeted therapy for tumours with EGFR, ALK, ROS1, KRAS G12C, BRAF or other alterations, and immunotherapy (checkpoint inhibitors) guided by PD-L1. Which applies is decided by your tumour testing, not a template.
Because targeted and immunotherapy choices hinge on the tumour’s molecular profile, genetic and biomarker testing is a standard part of the workup. See how these modalities work in general on the treatments & technology hub.
What it costs
There is no single lung-cancer price, because the cost is driven by whether surgery is done and how (open resection versus minimally invasive VATS), the number of chemotherapy cycles, whether radiation such as SBRT is used, and above all whether targeted or immunotherapy drugsare added — those are priced per cycle and can dominate the total, sometimes over many months. Every figure OncologyIstanbul™ publishes today is an illustrative placeholder pending verified partner-hospital quotes, and each is itemized so you can hold a real quote up against it line by line. See the Turkey Oncology Price Index or the full cancer treatment cost in Turkey breakdown.
The hospital, verified
We don’t show a wall of smiling surgeons or a “ranked” list — those are the easiest things to fabricate. Instead, you’re matched to one state-authorized Istanbul partner hospital whose thoracic and medical oncology subspecialty fits your diagnosis, and you can verify its authorization against the Republic of Turkey Ministry of Health’s own records and its JCI accreditation in JCI’s public directory before you commit. Named specialist profiles appear only when a verified, consented physician is behind the name. See the full guide to cancer hospitals in Istanbul and how to check one yourself.
Where this fits
This is one diagnosis within the broader cancer treatment in Istanbul pillar. Because lung cancer plans hinge on the tumour type and its molecular profile, a free second opinion organizes and verifies your pathology, imaging and any biomarker results into a plain-language case file in your language before you decide whether to travel.
Related cancers
You might also look at
Check everything here — us included
Common questions
Can I get lung cancer treatment in Turkey?
Yes. Istanbul hospitals provide the full lung-cancer pathway the U.S. National Cancer Institute describes — surgery to remove part of a lung (a lobectomy, often minimally invasive by VATS) for early non-small cell disease, radiation therapy including stereotactic body radiation for small inoperable tumours, chemotherapy, and biomarker-driven targeted therapy and immunotherapy for advanced disease. Many centers hold JCI accreditation and Turkish Ministry of Health state authorization, both of which you can check yourself before you commit. The honest first step is a free case review of your pathology, imaging and any molecular testing so the plan is understood before you travel.
How does treatment differ between NSCLC and SCLC?
They are treated very differently, which is why the exact type matters. Per the NCI, non-small cell lung cancer (about 85% of cases) is often driven by surgery when it is caught early, with radiation, chemotherapy, and biomarker-guided targeted or immunotherapy layered in by stage. Small cell lung cancer tends to grow and spread faster and is usually treated with chemotherapy and radiation rather than surgery, because it is often widespread by the time it is found. Your pathology report states which type you have, and a case review confirms that the plan matches it. This is general information, not a treatment recommendation.
Why is biomarker and PD-L1 testing essential in lung cancer?
Because in non-small cell lung cancer it decides which drugs can work. Per the NCI, tumours are tested for molecular alterations such as EGFR, ALK, ROS1, KRAS G12C and BRAF — when one is present, a matched targeted therapy is often used instead of, or before, standard chemotherapy. Tumours are also tested for the PD-L1 protein, which helps guide immunotherapy with checkpoint inhibitors. Without this testing a targetable case can be missed entirely, so it is a standard part of the modern workup. A case review flags whether the testing has already been done on your reports.
How much does lung cancer treatment cost in Istanbul?
There is no single figure, because the cost is driven by whether surgery is done and how (open resection versus minimally invasive VATS), the number of chemotherapy cycles, whether radiation such as SBRT is used, and above all whether targeted or immunotherapy drugs are added — those drugs are priced per cycle and can dominate the total, sometimes for many months. Istanbul typically runs well below Western-European prices for the same protocol, but every figure OncologyIstanbul™ publishes today is an illustrative placeholder pending verified partner-hospital quotes, itemized so you can check a real written quote line by line. See the Turkey Oncology Price Index for current ranges.
Start with a free 72-hour case review
Send your pathology and imaging. Get a verified case file in your language — free, confidential, no obligation.
This page is general information, not medical advice. Medical facts are grounded in the U.S. National Cancer Institute; prices shown are illustrative placeholders pending verified partner-hospital quotes, not offers. Every cancer case is individual; assessments are based on the reports you provide and do not replace in-person examination.